STEPHANIE HILL: Open Payments
NPI 1437631801 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 37 payments from 9 companies in 2025. Trend: 2023 $663 · 2024 $830 · 2025 $1,305
Food & beverage: $1,249Education: $56
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $652 |
| GENZYME CORPORATION | 7 | $229 |
| Optinose US, Inc. | 1 | $122 |
| GlaxoSmithKline, LLC. | 4 | $85 |
| Boston Scientific Corporation | 3 | $72 |
| Amgen Inc. | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| ABBVIE INC. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
Products named: DUPIXENT, Xhance, NUCALA, WaveWriter Alpha Prime 16, TEZSPIRE, UBRELVY.
Industry payments across AL — which companies pay providers there.
